Perrigo recommends shareholders reject Mylan's tender offer

(Reuters) - Generic and over-the-counter drugmaker Perrigo Co on Thursday urged its shareholders to reject Mylan NV's unsolicited $27 billion tender offer, saying it substantially undervalued the company.